Montclaire, CA – Ingredients by Nature (IBN)—supplier and manufacturer of innovative customizable, science-based nutraceutical ingredients—has acquired the Sytrinol® brand, including marketing assets associated with the brand such as logos, web domains, human clinicals, patents and marketing data. IBN is committed to providing the same level of service and quality that brand partners have come to expect and that new customers can look forward to.
IBN is widely recognized for its expertise in citrus ingredients and the addition of Sytrinol® is a great fit into its existing portfolio. IBN knows the formulation of the ingredient intimately, having manufactured the Sytrinol® formula for many years prior to the acquisition. This includes years of experience manufacturing citrus-derived polymethoxylated flavones (PMFs), a key ingredient in this newly acquired blend of citrus and palm fruit extracts.
Sytrinol® provides powerful support for heart health by influencing healthy cholesterol levels, healthy LDL levels with improved LDL:HDL ratio, and healthy triglyceride levels. And research has shown that its positive effects are measurable in as little as 4 weeks. The randomized, double-blind, placebo-controlled research showed a 27 percent reduction in cholesterol levels, 25 percent reduction in LDL cholesterol levels, and 31 percent reduction in triglyceride levels. The extent to which the ingredient functions has rarely been seen with other heart health ingredients.
“Having worked with the Sytrinol® formulation for a long time, we couldn’t be happier to have this brand underneath our umbrella of citrus-derived ingredients,” said Rob Brewster, president of IBN. “The science speaks for itself that this is among the best available ingredients for heart health, and we look forward to discovering additional ways to innovate with Sytrinol® to bring it to an expanded consumer base.”
Now, with full control of the formulation, IBN plans to explore the synergistic combination of its clinically backed lemon flavonoid brand Eriomin™️ with Sytrinol®. Launched in 2019, Eriomin™ delivers a tri-pronged approach to prediabetes management by helping to address insulin resistance, pro-inflammatory cytokine production and oxidative stress. Excessive blood glucose has been linked to unhealthy cholesterol and triglyceride levels, so by adding in Sytrinol’s heart health benefits, the combo may have even greater potential for prediabetes management and cardiovascular support.
To learn more about Sytrinol® and Eriomin™, contact us at IngredientsByNature.com.
About Ingredients by Nature
With over 80 years of experience in the natural products industry, Ingredients by Nature (IBN) formulates, manufactures and markets science-based ingredients, proprietary extracts and formula innovations for applications in dietary supplements, functional foods & beverages, cosmetics and animal nutrition. IBN currently offers more than 300 ingredient variations, including probiotics and various citrus-derived ingredients—flavonoids and fibers—along with its custom, contract manufacturing and powder processing services. In 2019, IBN launched its lemon flavonoid blend Eriomin which supports efforts toward improved prediabetes management and a healthy gaming lifestyle.
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.